Guidelines for Antifungal Therapy

Published in Internal Medicine Journal 44 (2014) 1267-1397.

1. Introduction to the updated Australian and New Zealand consensus guidelines for the use of antifungal agents in the haematology/oncology setting, 2014. 
   Internal Medicine Journal 44:1267-1276.
2. Survey of antifungal prophylaxis and fungal diagnostic tests employed in malignant haematology and haemopoietic stem cell transplantation (HSCT) in Australia and New Zealand
   Internal Medicine Journal 44:2014:1277-1282
3. Consensus guidelines for antifungal prophylaxis in haematological malignancy and haemopoietic stem cell transplantation, 2014 
   Internal Medicine Journal 44:2014:1283-1297
4. Consensus guidelines for the use of empiric and diagnostic-driven antifungal treatment strategies in haematological malignancy, 2014 
   Internal Medicine Journal 44:2014:1298-1314
5. Consensus guidelines for the treatment of yeast infections in the haematology, oncology and intensive care setting, 2014 
   Internal Medicine Journal 44:2014:1315-1332
6. Consensus guidelines for the treatment of invasive mould infections in haematological malignancy and haemopoietic stem cell transplantation, 2014 
   Internal Medicine Journal 44:2014:1333-1349
7. Consensus guidelines for diagnosis, prophylaxis and management of Pneumocystis jirovecii pneumonia in patients with haematological and solid malignancies, 2014 
   Internal Medicine Journal 44:2014:1350-1363
8. Consensus guidelines for optimising antifungal drug delivery and monitoring to avoid toxicity and improve outcomes in patients with haematological malignancy, 2014 
   Internal Medicine Journal 44:2014:1364-1388
9. Consensus guidelines for implementation of quality processes to prevent invasive fungal disease and enhanced surveillance measures during hospital building works, 2014 
   Internal Medicine Journal 44:2014:1389-1397

Published in Clin Microbiol Infect 2014; 20 (Suppl. 3): 76–98

• ESCMID and ECMM joint clinical guidelines for the diagnosis andmanagement of rare invasive yeast infections.

Published in Clinical Microbiology and Infection 2011, 17, (supplement 5): 1-12

• Management of invasive candidiasis in adults

Website: www.idsociety.org - Published in Clinical Infectious Diseases

1. Guidelines introduction 2000 (CID 2000;30:652)
2. Antifungal agents 2000 (CID 2000;30:653–7)
3. Aspergillosis 2008 (CID 2008;46:327–360)
4. Blastomycosis 2008 (CID 2008;46:1801–1812)
5. Candidiasis 2009 (CID 2009;48:503–535)
6. Coccidioidomycosis 2008 (CID 2005;41:1217–1223)
7. Cryptococcosis 2010 (CID 2010;50:291-322)
8. Histoplasmosis 2007 (CID 2007;45:807–25)
9. Sporotrichosis 2007 (CID 2007; 5:1255–65)

The ECIL-1 is a common initiative of the following groups or organisations: Infectious Diseases Working Party of the European Blood and Marrow Transplantation Group (EBMT-IDWP), Infectious Diseases Group of the European Organization for Research and Treatment of Cancer (EORTC-IDG), European Leukemia Net (ELN) (EU Grant No.: LSHC-CT-2004), and International Immunocompromised Host Society (ICHS).

1. Empirical antifungal therapy in neutropaenic cancer patients with persistent fever (EJC Supplement S5:2007:32-42)
2. Primary antifungal prophylaxis in leukaemia patients (EJC Supplement S5:2007:43-48)
3. Treatment of invasive Candida and invasive Aspergillus infections in adult haematological patients (EJC Supplement S5:2007:49-59)
4. European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3—2009 Update (Bone Marrow Transplantation 2011, 46:709-718)

5. European guidelines for primary antifungal prophylaxis in adult haematology patients: summary of the updated recommendations from the European Conference on Infections in Leukaemia. Antimicrob Chemother 2018; 73: 3221–3230.

An Official American Thoracic Society Statement: Treatment of Fungal Infections in Adult Pulmonary and Critical Care Patients. Limper et al. 2011 Am J Respir Crit Care Med Vol 183. pp 96–128. Internet address: www.atsjournals.org

• Treatment of fungal infections in adult pulmonary and critical care patients

Prentice et al. 2010, British Society for Haematology

• Guidelines on the management of invasive fungal infection during therapy for haematological malignancy

Published in British Journal of Dermatology 2000-2003

• Guidelines for the treatment of onychomycosis (Roberts et al. 2003 BJD 148:402-410)
• Guidelines for the management of tinea capitis (Higgins et al. 2000 BJD 143:53-58)

Richardson, M.D. and B.L. Jones Current Medical Literature 3rd edition 2003

• Therapeutic guidelines in systemic fungal infection